Article Text

Download PDFPDF
Vision restoration therapy and raising red flags too early

Statistics from


  • Competing interests: BAS is a shareholder of and consultant to NovaVision, the manufacturer of vision restoration therapy (VRT). NovaVision has also supported research studies conducted in the laboratory of BAS.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.